ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Cook Ireland, Ltd. · Decision date Nov 14, 2012
What did the FDA approve?
FDA records P100022 as an original PMA application. The recorded decision is approval, dated Nov 14, 2012.
FDA approval order statement
APPROVAL FOR THE ZILVER PTX DRUG-ELUTING PERIPHERAL STENT. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER FOR THE TREATMENT OF DE NOVO OR RESTENOTIC SYMPTOMATIC LESIONS IN NATIVE VASCULAR DISEASE OF THE ABOVE-THE-KNEE FEMOROPOPLITEAL ARTERIES HAVING REFERENCE VESSEL DIAMETERS FROM 4 MM TO 9 MM AND TOTAL LESION LENGTHS UP TO 140 MM PER LIMB AND 280 MM PER PATIENT.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 14, 2012
Regulatory record facts
- Identifier
- P100022
- Regulatory pathway
- Premarket approval application
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIU
- Decision code
- APPR
- Decision date
- Nov 14, 2012
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, superficial femoral artery, drug-eluting.
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIU
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P100022 received
Application receipt date recorded by FDA.
P100022 · FDA decision
APPR
P100022/S046 · Related supplement
Zilver PTX Drug-Eluting Peripheral Stent
Timeline entries are records held by MedtechLedger for P100022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Zilver PTX Drug-Eluting Peripheral StentP100022/S046 | Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P100022
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records